Finance

Beta
Lists
W5L:FRA
Chosa Oncology AB
€0.073
+23.57%
(+0.014) 1D
Jul 15, 8:02:06 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for W5L...
Open
€0.07
High
€0.07
Low
€0.07
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.15
52-wk low
€0.03
No. of employees
2
Open
€0.07
High
€0.07
Low
€0.07
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.15
52-wk low
€0.03
No. of employees
2
News stories
From sources across the web
About Chosa Oncology AB
CEO-
Employees2
Founded2007
Headquarters-
SectorBiotechnology
Websitechosaoncology.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.94M
-
676.00K
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.02M
2.48M
4.07M
1.96M
Operating expense
1.43M
2.49M
5.40M
1.96M
Total operating expenses
1.43M
2.49M
5.40M
1.96M
Operating income
2.51M
-2.49M
-4.72M
-1.96M
Other non operating income
119.00K
-52.00K
-8.75K
-2.00K
EBT including unusual items
2.64M
-2.54M
-4.92M
-1.87M
EBT excluding unusual items
2.64M
-2.54M
-4.92M
-1.87M
Income tax expense
-
-
-1.01M
-
Effective tax rate
-
-
20.60%
-
Other operating expenses
-677.00K
5.00K
680.00K
-2.00K
Net income
2.64M
-2.54M
-3.91M
-1.87M
Net profit margin
67.22%
-
-578.11%
-
Earnings per share
-
-
-
-
Interest and investment income
18.00K
-
310.20K
95.00K
Interest expense
-
-
-116.05K
-2.00K
Net interest expenses
18.00K
-
194.16K
93.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
2.68M
-2.46M
-4.08M
-1.78M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer